Centessa Pharmaceuticals (CNTA) Free Cash Flow: 2022-2025
Historic Free Cash Flow for Centessa Pharmaceuticals (CNTA) over the last 4 years, with Sep 2025 value amounting to -$58.5 million.
- Centessa Pharmaceuticals' Free Cash Flow fell 173.29% to -$58.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$181.0 million, marking a year-over-year decrease of 38.87%. This contributed to the annual value of -$142.1 million for FY2024, which is 11.48% up from last year.
- Centessa Pharmaceuticals' Free Cash Flow amounted to -$58.5 million in Q3 2025, which was down 160.76% from -$22.5 million recorded in Q2 2025.
- In the past 5 years, Centessa Pharmaceuticals' Free Cash Flow registered a high of -$21.4 million during Q3 2024, and its lowest value of -$60.1 million during Q2 2022.
- Its 3-year average for Free Cash Flow is -$40.1 million, with a median of -$40.6 million in 2024.
- Examining YoY changes over the last 5 years, Centessa Pharmaceuticals' Free Cash Flow showed a top increase of 44.67% in 2025 and a maximum decrease of 173.29% in 2025.
- Centessa Pharmaceuticals' Free Cash Flow (Quarterly) stood at -$52.2 million in 2022, then skyrocketed by 40.48% to -$31.1 million in 2023, then tumbled by 37.72% to -$42.8 million in 2024, then crashed by 173.29% to -$58.5 million in 2025.
- Its last three reported values are -$58.5 million in Q3 2025, -$22.5 million for Q2 2025, and -$57.2 million during Q1 2025.